|
|
 |
|
Viewing report
|
|
|
|
Other OTC Healthcare Products Market in South Korea to 2014 (OTC Healthcare)
Datamonitor, Feb 2011, Pages: 29
Introduction
This databook provides key data and information on the Other OTC Healthcare Products Market in South Korea (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
-Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
-Category level company and brand share as well as distribution share information for 2007 and 2008
Highlights
Other OTC healthcare products category was valued at KRW43,795.1m ($39.7m) in 2009, representing a CAGR of 7.1% since 2004.
By the end of 2014, other OTC healthcare products category will be worth KRW63,801.7m ($57.9m), with an expected CAGR of 7.8% between 2009 and 2014.
Other OTC healthcare products market was led by motion sickness (representing 44.4% of the total value) followed by eye / ear drops and anti-smoking aids, with a 21.6% and 17.8% market share, respectively. Rectal medications accounts for the remaining 16.2% share.
Novartis AG is the market leader with a 17.5% share of the market.
Reasons to Purchase
-Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in South Korea (OTC Healthcare)
-Design effective marketing and sales strategies by identifying key market categories and segments
-Identify key players within the market to plan lucrative M&A, partnerships and agreements
|
|
|
|
